Immunopathology of rheumatoid arthritis

Current Topics in Medicinal Chemistry

Volumn 13, Issue 6, 2013, Pages 705-711

  Pablos, José L ^a   Cañete, Juan D ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Autoantibodies; B cells; Cytokines; Rheumatoid arthritis; Synovial pathology; T cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AUTOANTIBODY; CD16 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DECAY ACCELERATING FACTOR; HEAT SHOCK PROTEIN 47; HLA ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 6; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; AUTOIMMUNITY; BONE DESTRUCTION; CARTILAGE DEGENERATION; CELL INFILTRATION; CHRONIC INFLAMMATION; ENVIRONMENTAL FACTOR; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOLOGY; IMMUNOPEROXIDASE STAINING; JOINT BIOPSY; NONHUMAN; OSTEOARTHRITIS; OSTEOCLASTOGENESIS; PATHOGENESIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS;

EID: 84878772258     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313060003     Document Type: Article

References (77)

1. McInnes, I.B.; Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med., 2011, 365(23), 2205-2219.
2. Firestein, G.S. Evolving concepts of rheumatoid arthritis. Nature, 2003, 423(6937), 356-361.
3. Humby, F.; Bombardieri, M.; Manzo, A.; Kelly, S.; Blades, M.C.; Kirkham, B.; Spencer, J.; Pitzalis, C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med., 2009, 6(1), e1.
4. Schroder, A.E.; Greiner, A.; Seyfert, C.; Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. U S A, 1996, 93(1), 221-225.
5. Karouzakis, E.; Neidhart, M.; Gay, R.E.; Gay, S. Molecular and cellular basis of rheumatoid joint destruction. Immunol. Lett., 2006, 106(1), 8-13.
6. Jimenez-Boj, E.; Nobauer-Huhmann, I.; Hanslik-Schnabel, B.; Dorotka, R.; Wanivenhaus, A.H.; Kainberger, F.; Trattnig, S.; Axmann, R.; Tsuji, W.; Hermann, S.; Smolen, J.; Schett, G. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum., 2007, 56(4), 1118-1124.
7. De Rycke, L.; Peene, I.; Hoffman, I.E.; Kruithof, E.; Union, A.; Meheus, L.; Lebeer, K.; Wyns, B.; Vincent, C.; Mielants, H.; Boullart, L.; Serre, G.; Veys, E.M.; De Keyser, F. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann. Rheum. Dis., 2004, 63(12), 1587-1593.
8. Klareskog, L.; Ronnelid, J.; Lundberg, K.; Padyukov, L.; Alfredsson, L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol., 2008, 26(651-675.
9. Nielen, M.M.; van Schaardenburg, D.; Reesink, H.W.; van de Stadt, R.J.; van der Horst-Bruinsma, I.E.; de Koning, M.H.; Habibuw, M.R.; Vandenbroucke, J.P.; Dijkmans, B.A. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum., 2004, 50(2), 380-386.
10. Rantapaa-Dahlqvist, S.; de Jong, B.A.; Berglin, E.; Hallmans, G.; Wadell, G.; Stenlund, H.; Sundin, U.; van Venrooij, W.J. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum., 2003, 48(10), 2741-2749.
11. van der Woude, D.; Rantapaa-Dahlqvist, S.; Ioan-Facsinay, A.; Onnekink, C.; Schwarte, C.M.; Verpoort, K.N.; Drijfhout, J.W.; Huizinga, T.W.; Toes, R.E.; Pruijn, G.J. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann. Rheum. Dis., 2010, 69(8), 1554-1561.
12. Scheinecker, C.; Redlich, K.; Smolen, J.S. Cytokines as therapeutic targets: advances and limitations. Immunity, 2008, 28(4), 440-444.
13. Alessandri, C.; Bombardieri, M.; Papa, N.; Cinquini, M.; Magrini, L.; Tincani, A.; Valesini, G. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann. Rheum. Dis., 2004, 63(10), 1218-1221.
14. Brown, A.K.; Quinn, M.A.; Karim, Z.; Conaghan, P.G.; Peterfy, C.G.; Hensor, E.; Wakefield, R.J.; O'Connor, P.J.; Emery, P. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum., 2006, 54(12), 3761-3773.
15. Knevel, R.; Schoels, M.; Huizinga, T.W.; Aletaha, D.; Burmester, G.R.; Combe, B.; Landewe, R.B.; Smolen, J.S.; Sokka, T.; van der Heijde, D.M. Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann. Rheum. Dis., 2010, 69(6), 987-994.
16. Montes, A.; Perez-Pampin, E.; Calaza, M.; Gomez-Reino, J.J.; Gonzalez, A. Association of anti-citrullinated vimentin and anticitrullinated alpha-enolase antibodies with subsets of rheumatoid arthritis. Arthritis Rheum., 2012, 64(10), 3102-3110.
17. Arlestig, L.; Mullazehi, M.; Kokkonen, H.; Rocklov, J.; Ronnelid, J.; Dahlqvist, S.R. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann. Rheum. Dis., 2012, 71(6), 825-829.
18. Mandik-Nayak, L.; Wipke, B.T.; Shih, F.F.; Unanue, E.R.; Allen, P.M. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc. Natl. Acad. Sci. U S A, 2002, 99(22), 14368-14373.
19. Samuels, J.; Ng, Y.S.; Coupillaud, C.; Paget, D.; Meffre, E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med., 2005, 201(10), 1659-1667.
20. Samuels, J.; Ng, Y.S.; Coupillaud, C.; Paget, D.; Meffre, E. Human B cell tolerance and its failure in rheumatoid arthritis. Ann. N. Y. Acad. Sci., 2005, 1062(116-126.
21. Kallberg, H.; Padyukov, L.; Plenge, R.M.; Ronnelid, J.; Gregersen, P.K.; van der Helm-van Mil, A.H.; Toes, R.E.; Huizinga, T.W.; Klareskog, L.; Alfredsson, L. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am. J. Hum. Genet., 2007, 80(5), 867-875.
22. Klareskog, L.; Stolt, P.; Lundberg, K.; Kallberg, H.; Bengtsson, C.; Grunewald, J.; Ronnelid, J.; Harris, H.E.; Ulfgren, A.K.; Rantapaa-Dahlqvist, S.; Eklund, A.; Padyukov, L.; Alfredsson, L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum., 2006, 54(1), 38-46.
23. Mahdi, H.; Fisher, B.A.; Kallberg, H.; Plant, D.; Malmstrom, V.; Ronnelid, J.; Charles, P.; Ding, B.; Alfredsson, L.; Padyukov, L.; Symmons, D.P.; Venables, P.J.; Klareskog, L.; Lundberg, K. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat. Genet., 2009, 41(12), 1319-1324.
24. Wegner, N.; Wait, R.; Sroka, A.; Eick, S.; Nguyen, K.A.; Lundberg, K.; Kinloch, A.; Culshaw, S.; Potempa, J.; Venables, P.J. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum., 2010, 62(9), 2662-2672.
25. Wilsher, M.; Voight, L.; Milne, D.; Teh, M.; Good, N.; Kolbe, J.; Williams, M.; Pui, K.; Merriman, T.; Sidhu, K.; Dalbeth, N. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir. Med., 2012, 106(10), 1441-1446.
26. Rangel-Moreno, J.; Hartson, L.; Navarro, C.; Gaxiola, M.; Selman, M.; Randall, T.D. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest., 2006, 116(12), 3183-3194.
27. Snir, O.; Widhe, M.; Hermansson, M.; von Spee, C.; Lindberg, J.; Hensen, S.; Lundberg, K.; Engstrom, A.; Venables, P.J.; Toes, R.E.; Holmdahl, R.; Klareskog, L.; Malmstrom, V. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum., 2010, 62(1), 44-52.
28. Reparon-Schuijt, C.C.; van Esch, W.J.; van Kooten, C.; Schellekens, G.A.; de Jong, B.A.; van Venrooij, W.J.; Breedveld, F.C.; Verweij, C.L. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum., 2001, 44(1), 41-47.
29. Scheel, T.; Gursche, A.; Zacher, J.; Haupl, T.; Berek, C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum., 2011, 63(1), 63-72.
30. van de Sande, M.G.; de Hair, M.J.; van der Leij, C.; Klarenbeek, P.L.; Bos, W.H.; Smith, M.D.; Maas, M.; de Vries, N.; van Schaardenburg, D.; Dijkmans, B.A.; Gerlag, D.M.; Tak, P.P. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann. Rheum. Dis., 2011, 70(5), 772-777.
31. Canete, J.D.; Celis, R.; Moll, C.; Izquierdo, E.; Marsal, S.; Sanmarti, R.; Palacin, A.; Lora, D.; de la Cruz, J.; Pablos, J.L. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann. Rheum. Dis., 2009, 68(5), 751-756.
32. Cantaert, T.; Kolln, J.; Timmer, T.; van der Pouw Kraan, T.C.; Vandooren, B.; Thurlings, R.M.; Canete, J.D.; Catrina, A.I.; Out, T.; Verweij, C.L.; Zhang, Y.; Tak, P.P.; Baeten, D. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J. Immunol., 2008, 181(1), 785-794.
33. Canete, J.D.; Santiago, B.; Cantaert, T.; Sanmarti, R.; Palacin, A.; Celis, R.; Graell, E.; Gil-Torregrosa, B.; Baeten, D.; Pablos, J.L. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann. Rheum. Dis., 2007, 66(6), 720-726.
34. Matsumoto, I.; Maccioni, M.; Lee, D.M.; Maurice, M.; Simmons, B.; Brenner, M.; Mathis, D.; Benoist, C. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol., 2002, 3(4), 360-365.
35. Hoek, R.M.; de Launay, D.; Kop, E.N.; Yilmaz-Elis, A.S.; Lin, F.; Reedquist, K.A.; Verbeek, J.S.; Medof, M.E.; Tak, P.P.; Hamann, J. Deletion of either CD55 or CD97 ameliorates arthritis in mouse models. Arthritis Rheum., 2010, 62(4), 1036-1042.
36. Itoh, J.; Nose, M.; Fujita, T.; Kato, M.; Ohyama, A.; Kyogoku, M. Expression of decay-accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis. Clin. Exp. Immunol., 1991, 83(3), 364-368.
37. Wang, Q.; Rozelle, A.L.; Lepus, C.M.; Scanzello, C.R.; Song, J.J.; Larsen, D.M.; Crish, J.F.; Bebek, G.; Ritter, S.Y.; Lindstrom, T.M.; Hwang, I.; Wong, H.H.; Punzi, L.; Encarnacion, A.; Shamloo, M.; Goodman, S.B.; Wyss-Coray, T.; Goldring, S.R.; Banda, N.K.; Thurman, J.M.; Gobezie, R.; Crow, M.K.; Holers, V.M.; Lee, D.M.; Robinson, W.H. Identification of a central role for complement in osteoarthritis. Nat. Med., 2011, 17(12), 1674-1679.
38. Maccioni, M.; Zeder-Lutz, G.; Huang, H.; Ebel, C.; Gerber, P.; Hergueux, J.; Marchal, P.; Duchatelle, V.; Degott, C.; van Regenmortel, M.; Benoist, C.; Mathis, D. Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med., 2002, 195(8), 1071-1077.
39. Terato, K.; Hasty, K.A.; Reife, R.A.; Cremer, M.A.; Kang, A.H.; Stuart, J.M. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol., 1992, 148(7), 2103-2108.
40. Ji, H.; Ohmura, K.; Mahmood, U.; Lee, D.M.; Hofhuis, F.M.; Boackle, S.A.; Takahashi, K.; Holers, V.M.; Walport, M.; Gerard, C.; Ezekowitz, A.; Carroll, M.C.; Brenner, M.; Weissleder, R.; Verbeek, J.S.; Duchatelle, V.; Degott, C.; Benoist, C.; Mathis, D. Arthritis critically dependent on innate immune system players. Immunity, 2002, 16(2), 157-168.
41. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 2007, 447(7145), 661-678.
42. Goodnow, C.C. Multistep pathogenesis of autoimmune disease. Cell, 2007, 130(1), 25-35.
43. Freed, B.M.; Schuyler, R.P.; Aubrey, M.T. Association of the HLA-DRB1 epitope LA(67, 74) with rheumatoid arthritis and citrullinated vimentin binding. Arthritis Rheum., 2011, 63(12), 3733-3739.
44. Law, S.C.; Street, S.; Yu, C.H.; Capini, C.; Ramnoruth, S.; Nel, H.J.; van Gorp, E.; Hyde, C.; Lau, K.; Pahau, H.; Purcell, A.W.; Thomas, R. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res. Ther., 2012, 14(3), R118.
45. Wing, K.; Yamaguchi, T.; Sakaguchi, S. Cell-autonomous and-non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol., 2011, 32(9), 428-433.
46. Menard, L.; Saadoun, D.; Isnardi, I.; Ng, Y.S.; Meyers, G.; Massad, C.; Price, C.; Abraham, C.; Motaghedi, R.; Buckner, J.H.; Gregersen, P.K.; Meffre, E. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest., 2011, 121(9), 3635-3644.
47. Vang, T.; Congia, M.; Macis, M.D.; Musumeci, L.; Orru, V.; Zavattari, P.; Nika, K.; Tautz, L.; Tasken, K.; Cucca, F.; Mustelin, T.; Bottini, N. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet., 2005, 37(12), 1317-1319.
48. Behrens, F.; Himsel, A.; Rehart, S.; Stanczyk, J.; Beutel, B.; Zimmermann, S.Y.; Koehl, U.; Moller, B.; Gay, S.; Kaltwasser, J.P.; Pfeilschifter, J.M.; Radeke, H.H. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Ann. Rheum. Dis., 2007, 66(9), 1151-1156.
49. Nadkarni, S.; Mauri, C.; Ehrenstein, M.R. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med., 2007, 204(1), 33-39.
50. Lan, Q.; Fan, H.; Quesniaux, V.; Ryffel, B.; Liu, Z.; Zheng, S.G. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J. Mol. Cell Biol., 2012, 4(1), 22-28.
51. Kremer, J.M.; Westhovens, R.; Leon, M.; Di Giorgio, E.; Alten, R.; Steinfeld, S.; Russell, A.; Dougados, M.; Emery, P.; Nuamah, I.F.; Williams, G.R.; Becker, J.C.; Hagerty, D.T.; Moreland, L.W. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med., 2003, 349(20), 1907-1915.
52. Miossec, P. Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium. Arthritis Res. Ther., 2008, 10 Suppl 1 S2.
53. Genovese, M.C.; Van den Bosch, F.; Roberson, S.A.; Bojin, S.; Biagini, I.M.; Ryan, P.; Sloan-Lancaster, J. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum., 2010, 62(4), 929-939.
54. Hueber, A.J.; Asquith, D.L.; Miller, A.M.; Reilly, J.; Kerr, S.; Leipe, J.; Melendez, A.J.; McInnes, I.B. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol., 2010, 184(7), 3336-3340.
55. Ma, J.; Zhu, C.; Ma, B.; Tian, J.; Baidoo, S.E.; Mao, C.; Wu, W.; Chen, J.; Tong, J.; Yang, M.; Jiao, Z.; Xu, H.; Lu, L.; Wang, S. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin. Dev. Immunol., 2012, 2012(827480.
56. Nakae, S.; Nambu, A.; Sudo, K.; Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol., 2003, 171(11), 6173-6177.
57. Platt, A.M.; Gibson, V.B.; Patakas, A.; Benson, R.A.; Nadler, S.G.; Brewer, J.M.; McInnes, I.B.; Garside, P. Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells. J. Immunol., 2010, 185(3), 1558-1567.
58. Hsu, H.C.; Yang, P.; Wang, J.; Wu, Q.; Myers, R.; Chen, J.; Yi, J.; Guentert, T.; Tousson, A.; Stanus, A.L.; Le, T.V.; Lorenz, R.G.; Xu, H.; Kolls, J.K.; Carter, R.H.; Chaplin, D.D.; Williams, R.W.; Mountz, J.D. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol., 2008, 9(2), 166-175.
59. Peters, A.; Pitcher, L.A.; Sullivan, J.M.; Mitsdoerffer, M.; Acton, S.E.; Franz, B.; Wucherpfennig, K.; Turley, S.; Carroll, M.C.; Sobel, R.A.; Bettelli, E.; Kuchroo, V.K. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity, 2011, 35(6), 986-996.
60. Cambridge, G.; Leandro, M.J.; Edwards, J.C.; Ehrenstein, M.R.; Salden, M.; Bodman-Smith, M.; Webster, A.D. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum., 2003, 48(8), 2146-2154.
61. Thurlings, R.M.; Vos, K.; Wijbrandts, C.A.; Zwinderman, A.H.; Gerlag, D.M.; Tak, P.P. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann. Rheum. Dis., 2008, 67(7), 917-925.
62. van de Veerdonk, F.L.; Lauwerys, B.; Marijnissen, R.J.; Timmermans, K.; Di Padova, F.; Koenders, M.I.; Gutierrez-Roelens, I.; Durez, P.; Netea, M.G.; van der Meer, J.W.; van den Berg, W.B.; Joosten, L.A. The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum., 2011, 63(6), 1507-1516.
63. Maini, R.N.; Feldmann, M. How does infliximab work in rheumatoid arthritis? Arthritis Res., 2002, 4 Suppl 2(S22-28.
64. van Amelsfort, J.M.; Jacobs, K.M.; Bijlsma, J.W.; Lafeber, F.P.; Taams, L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum., 2004, 50(9), 2775-2785.
65. Haringman, J.J.; Gerlag, D.M.; Zwinderman, A.H.; Smeets, T.J.; Kraan, M.C.; Baeten, D.; McInnes, I.B.; Bresnihan, B.; Tak, P.P. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis., 2005, 64(6), 834-838.
66. Nigrovic, P.A.; Lee, D.M. Synovial mast cells: role in acute and chronic arthritis. Immunol. Rev., 2007, 217(19-37.
67. Klimiuk, P.A.; Yang, H.; Goronzy, J.J.; Weyand, C.M. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin. Immunol., 1999, 90(1), 65-78.
68. Koenders, M.I.; Marijnissen, R.J.; Joosten, L.A.; Abdollahi-Roodsaz, S.; Di Padova, F.E.; van de Loo, F.A.; Dulos, J.; van den Berg, W.B.; Boots, A.M. T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization. Arthritis Rheum., 2012, 64(6), 1762-1770.
69. Yamada, H.; Nakashima, Y.; Okazaki, K.; Mawatari, T.; Fukushi, J.I.; Kaibara, N.; Hori, A.; Iwamoto, Y.; Yoshikai, Y. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann. Rheum. Dis., 2008, 67(9), 1299-1304.
70. Schett, G.; Teitelbaum, S.L. Osteoclasts and arthritis. J. Bone Miner. Res., 2009, 24(7), 1142-1146.
71. del Rey, M.J.; Izquierdo, E.; Caja, S.; Usategui, A.; Santiago, B.; Galindo, M.; Pablos, J.L. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum., 2009, 60(10), 2926-2934.
72. Izquierdo, E.; Canete, J.D.; Celis, R.; Del Rey, M.J.; Usategui, A.; Marsal, S.; Sanmarti, R.; Criado, G.; Pablos, J.L. Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy. Arthritis Rheum., 2011, 63(9), 2575-2583.
73. Izquierdo, E.; Canete, J.D.; Celis, R.; Santiago, B.; Usategui, A.; Sanmarti, R.; Del Rey, M.J.; Pablos, J.L. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One, 2009, 4(12), e8131.
74. Filer, A.; Raza, K.; Salmon, M.; Buckley, C.D. The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis. Front. Biosci., 2008, 13(2674-2685.
75. Neumann, E.; Lefevre, S.; Zimmermann, B.; Gay, S.; Muller-Ladner, U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol. Med., 2010, 16(10), 458-468.
76. Armaka, M.; Apostolaki, M.; Jacques, P.; Kontoyiannis, D.L.; Elewaut, D.; Kollias, G. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med., 2008, 205(2), 331-337.
77. Nikitopoulou, I.; Oikonomou, N.; Karouzakis, E.; Sevastou, I.; Nikolaidou-Katsaridou, N.; Zhao, Z.; Mersinias, V.; Armaka, M.; Xu, Y.; Masu, M.; Mills, G.B.; Gay, S.; Kollias, G.; Aidinis, V. Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J. Exp. Med., 2012, 209(5), 925-933.